| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| The focus on healthcare innovation is pivotal for driving advancements in pharmaceutical products and services. Alnylam Pharmaceuticals is leveraging cutting-edge technologies and research to develop novel therapies, which is a key emphasis in recent conferences. This theme reflects a proactive approach toward addressing unmet medical needs and enhancing patient outcomes. By prioritizing innovative healthcare solutions, the company positions itself at the forefront of the industry. |
| The price action of Alnylam Pharmaceuticals (ALNY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.ALNY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-11-20. The forces of Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Sentiment towards Fundamentals (0.4), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Valuation Sentiment (-1.2) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ALNY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 0%(0%) | 1 | 0.25% | 0.3 | 0.4 | -1 | |||||||
| 2025-11-19 | 0%(0%) | 1 | 0.25% | 0.4 | 0.5 | -1 | |||||||
| 2025-11-18 | 0%(0%) | 1 | 0.25% | 0.4 | 0.2 | -1 | |||||||
| 2025-11-17 | 0%(0%) | 1 | 0.25% | 0.7 | 0.9 | -1 | |||||||
| 2025-11-16 | 0%(0%) | 1 | 0.25% | 0.8 | 1 | -1 | |||||||
| 2025-11-15 | 0%(0%) | 1 | 0.25% | 0.9 | 2.5 | -1 | |||||||
| 2025-11-14 | 0%(0%) | 1 | 0.25% | 0.9 | 2.5 | -1 | |||||||
| 2025-11-13 | 0%(0%) | 1 | 0.25% | 1.1 | 3.4 | -1 | |||||||
| 2025-11-12 | 0%(0%) | 1 | 0.25% | 1 | 3.2 | -1 | |||||||
| 2025-11-11 | 0%(0%) | 1 | 0.25% | 1 | 3.4 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-20 17:09:35 Catalyst's decision to lower stock holdings can reflect concerns over market volatility and the perceived valuation of Alnylam Pharmaceuticals within a fluctuating market. |
| 2025-11-20 17:09:35 The context surrounding stock reductions may relate to potential regulatory impacts affecting the biopharmaceutical industry, which can influence investment decisions. |
| 2025-11-20 17:09:35 The focus on Alnylam Pharmaceuticals indicates broader trends within the biopharmaceutical industry as firms adapt and respond to shifting market dynamics. |
| 2025-11-20 17:09:35 The reduction of shares by a fund signals strategic reallocations in investments, reflecting ongoing investment activities in the biopharmaceutical sector. |
| 2025-11-20 17:09:35 The article discusses a significant decrease in stock holdings by Catalyst Funds Management in Alnylam Pharmaceuticals, indicating cautious sentiment about the company's performance. |